At the same time, before the start of treatment and after the end of the treatment course, the early morning venous blood of the enrolled patients was collected to determine the content of BDNF, and to explore the treatment mechanism of rTMS in patients with non-fluid aphasia after stroke from the perspective of cytokines, providing clinical and theoretical support for the clinical treatment of aphasia. Here, BDNF is linked to Aphasia.